Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

REPROCELL links up with Medicines Discovery Catapult
May 2019
SHARING OPTIONS:

GLASGOW, U.K.—REPROCELL Europe Ltd and Medicines Discovery Catapult have launched a strategic partnership, with REPROCELL joining Medicines Discovery Catapult’s Virtual R&D platform. The initiative is a national network of consultants, private sector CROs, lab and public sector centers of excellence that provide drug discovery expertise, services and virtual program management. REPROCELL, an accredited Research Tissue Bank, provides contract laboratory services regarding predictive human fresh tissue assays.
 
Dr. Karen Bingham, chief operating officer, REPROCELL Europe, said: “Ethically sourced human tissue samples are such an important resource for the prediction of efficacy and safety of novel drug compounds and are becoming increasingly important in the area of precision medicine. It’s crucial that the NHS, industry and academia work together through collaborations such as Medicines Discovery Catapult in order to maximize use of this precious resource.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.